S
SSRC
vs
S&P 500
S&P 500
Over the past 12 months, SSRC has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +21% growth.
Stocks Performance
SSRC vs S&P 500
Performance Gap
SSRC vs S&P 500
Performance By Year
SSRC vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
SentiSearch Inc
Glance View
SentiSearch, Inc. operates as a development stage company. The company is headquartered in New York City, New York and currently employs 1 full-time employees. The company went IPO on 2006-12-01. The firm holds the rights to the olfaction intellectual property assets and certain applications titled Nucleic Acids and Proteins of Insect OR83b odorant receptor genes. The olfaction intellectual property assets can be used in Odorant receptors; cloning of vertebrate pheromone receptors, and genes encoding insect odorant receptors and their uses. The firm's gene modification process applications focus on the isolation of genes that are ubiquitous among insects. In collaboration with Bayer CropScience, the Company is developing solutions to control and eradicate insect-borne diseases, such as malaria and dengue fever.
